B4
Owen Mumford has been at the forefront of medical device innovation for over 70 years, pioneering solutions that enhance patient care and improve healthcare outcomes worldwide. Established in 1952 by Ivan Owen and John Mumford, the company has grown into a global leader in medical device design and manufacturing, with a commitment to quality, sustainability, and patient-centred innovation.
Activate Business School is delighted to announce it is launching a new award to help develop and train health and care staff across Buckinghamshire Oxfordshire and Berkshire (BOB).
A fascinating interview with Thomas Hal Robson-Kanu, international professional football player and founder of The Turmeric Co, one of the UK’s fastest growing health brands.
Blenheim is set to host three days of competition as part of the European Transplant and Dialysis Games which will arrive in the UK next week (23rd-25th August) for the first time ever.
An injectable cure for inherited heart muscle conditions that can kill young people in the prime of their lives could be available within a few years, after an international team of researchers were announced as the winners of the British Heart Foundation’s Big Beat Challenge.
Health and Social Care students at Oxford Brookes University are set to benefit from state of the art technology that allows them to step into immersive scenarios, to prepare for real life clinical practice.
Dr. Obrey Alexis of Oxford Brookes University is leading a Basingstoke-based initiative highlighting how black men of African and Caribbean heritage are disproportionately affected by prostate cancer.
An Oxford estate agent is running Muscular Dystrophy UK’s 40th Oxford Town and Gown as part of his 40th birthday fitness challenge – and in memory of his late cousin.
Oxford Bus Company and Thames Travel are encouraging motorists to consider a minor change in their travel habits to help make a difference on Walk to Work Day.
Featuring health & wellbeing stories from The Wellbeing Generation, Penningtons Manches Cooper, Target PR and more.
The corporate team at Penningtons Manches Cooper has advised OxDX on the completion of its spin-out from Oxford University and its £2.6 million pre-seed funding. The funding will be used to develop its AI-powered diagnostic technology, which will be used to improve the speed, cost and accuracy of diagnostics worldwide.
